INOTUZUMAB OZOGAMICIN IS AN EFFECTIVE SALVAGE THERAPY IN RELAPSED/REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA WITH HIGH- RISK MOLECULAR FEATURES, INCLUDING TP53 LOSS